These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22370992)

  • 1. Effects of large doses of arachidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders: a double-blind, placebo-controlled, randomized trial.
    Yui K; Koshiba M; Nakamura S; Kobayashi Y
    J Clin Psychopharmacol; 2012 Apr; 32(2):200-6. PubMed ID: 22370992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic effects of larger doses of arachidonic acid added to DHA on social impairment and its relation to alterations of polyunsaturated fatty acids in individuals with autism spectrum disorders].
    Yui K; Koshiba M; Nakamura S; Onishi M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Jun; 31(3):117-24. PubMed ID: 21800702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fish oil supplementation on quality of life in a general population of older Dutch subjects: a randomized, double-blind, placebo-controlled trial.
    van de Rest O; Geleijnse JM; Kok FJ; van Staveren WA; Olderikkert MG; Beekman AT; de Groot LC
    J Am Geriatr Soc; 2009 Aug; 57(8):1481-6. PubMed ID: 19549020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study.
    Amminger GP; Berger GE; Schäfer MR; Klier C; Friedrich MH; Feucht M
    Biol Psychiatry; 2007 Feb; 61(4):551-3. PubMed ID: 16920077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-chain polyunsaturated fat supplementation in children with low docosahexaenoic acid intakes alters immune phenotypes compared with placebo.
    Mazurak VC; Lien V; Field CJ; Goruk SD; Pramuk K; Clandinin MT
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):570-9. PubMed ID: 18493214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential fatty acid supplementation of DHA and ARA and effects on neurodevelopment across animal species: a review of the literature.
    Davis-Bruno K; Tassinari MS
    Birth Defects Res B Dev Reprod Toxicol; 2011 Jun; 92(3):240-50. PubMed ID: 21678548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.
    Hamazaki K; Itomura M; Huan M; Nishizawa H; Sawazaki S; Tanouchi M; Watanabe S; Hamazaki T; Terasawa K; Yazawa K
    Nutrition; 2005 Jun; 21(6):705-10. PubMed ID: 15925295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of omega-3 polyunsaturated fatty acid supplementation on semen profile and enzymatic anti-oxidant capacity of seminal plasma in infertile men with idiopathic oligoasthenoteratospermia: a double-blind, placebo-controlled, randomised study.
    Safarinejad MR
    Andrologia; 2011 Feb; 43(1):38-47. PubMed ID: 21219381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.
    Voigt RG; Llorente AM; Jensen CL; Fraley JK; Berretta MC; Heird WC
    J Pediatr; 2001 Aug; 139(2):189-96. PubMed ID: 11487742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials.
    Hoffman DR; Boettcher JA; Diersen-Schade DA
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):151-8. PubMed ID: 19505812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of arachidonic acids on social behavior in patients with autism spectrum disorders].
    Yui K; Murphy D; Hamakawa H
    Seishin Shinkeigaku Zasshi; 2009; 111(11):1387-96. PubMed ID: 20217968
    [No Abstract]   [Full Text] [Related]  

  • 14. Docosahexaenoic acid in red blood cells of term infants receiving two levels of long-chain polyunsaturated fatty acids.
    Hoffman DR; Wheaton DK; James KJ; Tuazon M; Diersen-Schade DA; Harris CL; Stolz S; Berseth CL
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):287-92. PubMed ID: 16540798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of arachidonate-enriched triacylglycerol supplementation on serum fatty acids and platelet aggregation in healthy male subjects with a fish diet.
    Kusumoto A; Ishikura Y; Kawashima H; Kiso Y; Takai S; Miyazaki M
    Br J Nutr; 2007 Sep; 98(3):626-35. PubMed ID: 17445350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study.
    Lloyd-Still JD; Powers CA; Hoffman DR; Boyd-Trull K; Lester LA; Benisek DC; Arterburn LM
    Nutrition; 2006 Jan; 22(1):36-46. PubMed ID: 16226012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docosahexaenoic acid (DHA) supplementation in atopic eczema: a randomized, double-blind, controlled trial.
    Koch C; Dölle S; Metzger M; Rasche C; Jungclas H; Rühl R; Renz H; Worm M
    Br J Dermatol; 2008 Apr; 158(4):786-92. PubMed ID: 18241260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population.
    Stough C; Downey L; Silber B; Lloyd J; Kure C; Wesnes K; Camfield D
    Neurobiol Aging; 2012 Apr; 33(4):824.e1-3. PubMed ID: 21531481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder.
    Sandler AD; Sutton KA; DeWeese J; Girardi MA; Sheppard V; Bodfish JW
    N Engl J Med; 1999 Dec; 341(24):1801-6. PubMed ID: 10588965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of arachidonic, eicosapentaenoic and docosahexaenoic acids on the oxidative status of C6 glioma cells.
    Leonardi F; Attorri L; Di Benedetto R; Di Biase A; Sanchez M; Nardini M; Salvati S
    Free Radic Res; 2005 Aug; 39(8):865-74. PubMed ID: 16036367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.